Steering group KI - MSD
The KI-MSD partnership includes a joint steering group that decides which projects are to be included and which clinical studies can be considered.
The agreement sets the framework for a close collaboration in which researchers from both sides work together without imposing any limits on the scope of the research in advance. Investment decisions for the remainder of the collaboration will be taken continuously by the steering group, which comprises representatives from KI and MSD.
Here you can find the names and contact details of the Steering Group Members.
Contact for researchers at KI
Per Hall, professor at the Department of Medical Epidemiology and Biostatistics, KI.
Contact for stakeholders at MSD
Stina Salomonsson, Executive Director, Outcomes Research – CORE Regional Team lead, supporting RWE in Europe, Middle-East and Africa, MSD*
Other members in the Steering group
Richard Cowburn, PhD, Coordinator, KI.
Martin Neovius, professor at the Department of Medicine, Solna, KI.
Erik Dasbach, Executive Director, Outcomes Research – CORE Economic and Data Sciences, responsible for strategic partnerships, Merck & Co. Inc.
Ravinder Dhawan, Vice President, Outcomes research – CORE Oncology, leading the product line supporting oncology, Merck & Co. Inc.
Carol Koro, Executive Director, Outcomes Research – CORE Pharmacoepidemiology, supporting safety and follow up of vaccines, Merck & Co. Inc.
*Merck & Co. Inc. is named MSD outside the US and Canada.